-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Linzagolix Choline in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linzagolix Choline in Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linzagolix Choline in Pain Drug Details: Linzagolix (Yselty) is a small-molecule,...
-
Product Insights
Innovations in Pain Management – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Pain Management - Global Pipeline Summary" provides comprehensive information about the Pain Management pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Pain Management report provides key information and data related to: Extensive coverage of the Pain Management under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fluticasone Propionate in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fluticasone Propionate in Osteoarthritis Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fluticasone Propionate in Osteoarthritis Pain Drug Details: Fluticasone propionate (EP-104)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XT-150 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XT-150 in Osteoarthritis Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XT-150 in Osteoarthritis Pain Drug Details: XT-150 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Suzetrigine in Post-Operative Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Suzetrigine in Post-Operative Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Suzetrigine in Post-Operative Pain Drug Details: VX-548 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lyophilized Microbiota in Abdominal Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lyophilized Microbiota in Abdominal Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lyophilized Microbiota in Abdominal Pain Drug Details: The therapeutic candidate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OCT-461201 in Visceral Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OCT-461201 in Visceral Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OCT-461201 in Visceral Pain Drug Details: OCT-461201 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3556050 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3556050 in Osteoarthritis Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3556050 in Osteoarthritis Pain Drug Details: LY-3556050 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3857210 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3857210 in Osteoarthritis Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3857210 in Osteoarthritis Pain Drug Details: LY-3857210 under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Incobotulinumtoxin A in Peripheral Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Incobotulinumtoxin A in Peripheral Neuropathic Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Incobotulinumtoxin A in Peripheral Neuropathic Pain Drug Details: Incobotulinumtoxin...